Study of the effects of osthole on blood estradiol and lipase in animals and their relationship

Chinese Pharmacological Bulletin

Volumn 23, Issue 11, 2007, Pages

  Zhang, Yan ^a,b   Xie, Tao ^c   Xue, Jie ^a   Zhu, Lu Jia ^a   Hua, Yi Nan ^a   Xie, Mei Lin ^a   Gu, Zhen Lun ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b Maternal and Child Health Hospital of Wuxi   (China)

^c BINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Estradiol; Hepatic lipase; Lipoprotein lipase; Osthole

Indexed keywords

FENOFIBRATE; LIPOPROTEIN LIPASE; OSTHOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTRADIOL BLOOD LEVEL; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LIPID DIET; LOW DRUG DOSE; MOUSE; NONHUMAN; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 38349174514     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Deeb S S, Zambon A, Carr M C, et al. Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet[J]. J Lipid Res, 2003,44(7):1279-86.
2. Cai M B, Yi W D. Lipoprotein lipase Activator No-1886[J]. Chin Pharmacol Bull, 2004,20(3):251-4.
3. Yu A F, Wu YE, Ge Q S. Gynaecology and obstetries-endocrinol-ogy[M]. Shanghai: Shanghai Science and Technology Publishing Company, 1982:54-60.
4. Chen R, Xie M L, Zhou J. Experimental study of osthole on inhibition of thrombosis and platelet aggregation[J]. Chin Pharmacol Bull, 2005,21(4):440-3.
5. Liu J X, Zhang W P, Lian Q S. Phytoestrogen-like effect of Cnidium monnieri(L) cuss[J]. Chin J Clin Rehebil, 2005,9(23):186 -9.
6. Bao J J, Xie M L, Zhu L J, et al. Prevention of osthol on osteoporosis in ovariectomized rats [J]. Chin Pharm J, 2006,41(3):193-5.
7. Zhang S F, Chen F, Wu T. Establishment of hyperlipemic mouse model by long-term gastric perfusion of intralipid[J]. J Guangdong Med Coll, 2004,22(4):328-30.
8. Merkel M, Heeren J, Dudeck W, et al. Inactive lipoprotein lipase (LPL) alone increases selective cholesterol ester uptake in vivo, whereas in the presence of active LPL It also increases triglyceride hydrolysis and whole particle lipoprotein uptake[J]. J Biol Chem, 2002,277(9):7405-11.
9. de Man F H, de Beer F, van der Laarse A, et al. The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding[J]. Atherosclerosis, 2000,153(2):363-71.
10. Perret B, Mabile L, Martinez L, et al. Hepatic lipase: structure/ function relationship, synthesis, and regulation[J]. J Lipid Res, 2002,43(8):1163-9.
11. Santamarina-Fojo S, Gonzalez-Navarro H, Freeman L, et al. Hepatic lipase, lipoprotein metabolism, and atherogenesis[J]. Arterioscl Throm Vasc Biol, 2004,24(10):1750-4.
12. Gonzales-Navarro H, Nong Z, Amar M J, et al. The ligand-binding function of hepatic lipase modulates the development of atherosclerosis in transgenic mice[J]. J Biol Chem, 2004,279(44):45312 -21.
13. Duan JH, Xu H S, Dai S L, et al. Phytoestrogen a-Zearalanol inhibition of ox-LDL-induced endothelin-1 gene expression and antioxidation[J]. Chin Pharmacol Bull, 2006,22(8):930-4.
14. Mead J R, Irvine S A, Ramji D P. Lipoprotein lipase: structure, function, regulation, and role in disease[J]. J Mol Med, 2002,80 (1):753-69.
15. Yamakawa-Kobayashi K, Somekawa Y, Fujimura M, et al. Relation of the-514C/T polymorphism in the hepatic lipase gene to serum HDL and LDL cholesterol levels in postmenopausal women under hormone replacement therapy[J]. Atherosclerosi, 2002,162 (1):17-21.